期刊文献+

非那雄胺对大鼠前列腺微血管的影响 被引量:2

Effects of Finasteride on Capillary in the Ventral Prostate of Rat
暂未订购
导出
摘要 目的 评价非那雄胺对大鼠前列腺微血管的影响并探讨其机制。方法 非那雄胺 4 0 mg/ (kg· d)喂饲雄性 SD大鼠 7d(B组 ) ,14 d(C组 ) ,HE染色观察采用墨汁灌注染色的大鼠前列腺微血管密度 (MVD)的改变 ,免疫组织化学 SP法检测大鼠前列腺组织中血管内皮生长因子 (VEGF)及内皮型一氧化氮合酶 (e NOS)的蛋白表达。结果  B组、C组的 MVD较对照组 (A组 )分别下降了 35 .2 % ,5 6 % ;B组、C组的 VEGF的蛋白表达较 A组分别减少 31.7%及 6 2 .6 % ;e NOS的蛋白表达较 A组分别减少 15 .7%及 5 2 .5 %。结论 非那雄胺可抑制大鼠前列腺组织中 VEGF、e Objective To investigate the effects of finasteride on capillary in the ventral prostate of rat and study the mechanisms therein involved. Methods Male SD rats were given via gavage finasteride 40 mg/kg per day for 7 days (group B) and for 14 days (group C). The changes of capillary infused with Chinese ink were observed with the use of HE staining. Immunohistochemical (IHC) SP-method was adopted in measuring the protein expression of VEGF and eNOS in rat prostatic tissue. Results In comparison with the relevant values measured in the control group (group A), the microvessel density (MVD) values in group B and group C decreased by 35.2% and 56% respectively, the protein expression of VEGF in group B and group C decreased by 31.7% and 62.6% respectively, the protein expression of eNOS in group B and group C decreased by 15.7% and 52.5% respectively. Conclusion Finasteride can inhibit the protein expression of VEGF and eNOS and thereby can suppress angiogenesis of capillary in the ventral prostate of rat.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2004年第2期226-228,共3页 Journal of Sichuan University(Medical Sciences)
关键词 非那雄胺 前列腺 血管内皮生长因子 内皮型—氧化氮合酶 血管生成 Finasteride Prostate VEGF eNOS Angiogenesis
  • 相关文献

参考文献2

二级参考文献1

  • 1王忠 张元芳 等.血管内皮生长因子及其受体在肾细胞癌中的表达[J].中国医学杂志,1998,78(7):546-546.

共引文献16

同被引文献26

  • 1叶雄俊.非那雄胺对PSA的长期影响:一项来自前列腺癌预防试验的研究结果[J].中华泌尿外科杂志,2006,27(1):69-69. 被引量:2
  • 2蔡聪,蔡楚丹,洪汉业,何学军.抗生素联合非那雄胺治疗血精症的临床观察[J].中国医药,2007,2(1):54-55. 被引量:5
  • 3Price VH, Menefee E, Sanchez M, et al. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three-and 4-year results[J ] .J Am Acad Dermatol, 2006, 55(1) : 71.
  • 4Ryu HK, Kim KM, Yoo EA, et al. Evaluation of androgens in the scalp hair and plasma of patients with male- pattern baldness before and after finasteride administration [J ]. Br J Dermatol, 2006, 154(4) : 730.
  • 5Arca E, Acikgoz G, Tastan HB, et al. An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia[J].Dermatology, 2004,209(2) : 117.
  • 6Brown GA, Sussman DO. A current review of medical therapy for benign prostatic hyperplasia[J] .J Am Osteopath Assoc, 2004, 104(2 Suppl 2): S11.
  • 7D'Amico AV, Roehrborn CG. Effect of lmg/ day finasteride on concentralions of serum prostate - specific antigen in men with androgenic alopecia, a randomised controlled trial [J ] . Lancet Oncol, 2007,8(1) : 21.
  • 8Hasan M, Parveen F, Shamsuzzaman AK, et al. Comparison of efficacy between tamsulosin and finasteride on symptomatic benign prostatic hyperplasia[J].Mymensingh Med J , 2007,16(2) : 154.
  • 9Thompson IM, Tangen CM, Goodman P J, et al. Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection[J ] .J Urol, 2007,177(5) : 1 749.
  • 10D'Amico AV, Barry MJ. Prostate cancer prevention and finasteride[J].J Urol,2006,176( 5) :2 010.

引证文献2

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部